HealthReveal

HealthReveal is a clinical AI company in New York that focuses on enabling detection and treatment of chronic ailments at early stages. Founded 2015 in New York, United States by Frank Norman, Lonny Reisman, and Lori Evans Bernstein, HealthReveal has raised a total of $11.3M in funding over two rounds. Their latest funding was raised on May 12, 2017 from a Series A round. HealthReveal is funded by five investors. As of March 2020, Northwell Ventures and Flare Capital Partners are the most recent investors. The company's advanced analytics and biomonitoring technology continually monitors and analyzes patient physiology and care by integrating multiple real-time streams of clinical, operational and biometric data to ensure adherence to evidence-based care guidelines by clinicians and patients which helps patients.

HealthReveal is a clinical AI company in New York that focuses on enabling detection and treatment of chronic ailments at early stages. Founded 2015 in New York, United StatesUnited States by Frank Norman, Lonny Reisman, and Lori Evans Bernstein, HealthReveal has raised a total of $11.3M in funding over two rounds. Their latest funding was raised on May 12, 2017 from a Series A round. HealthReveal is funded by five investors. As of March 2020, Northwell Ventures and Flare Capital Partners are the most recent investors. The company's advanced analytics and biomonitoring technology continually monitors and analyzes patient physiology and care by integrating multiple real-time streams of clinical, operational and biometric data to ensure adherence to evidence-based care guidelines by clinicians and patients which helps patients.

HealthReveal is a clinical AI company in New York that focuses on enabling detection and treatment of chronic ailments at early stages. Founded 2015 in New York, United States by Frank Norman, Lonny Reisman, and Lori Evans Bernstein, HealthReveal has raised a total of $11.3M in funding over two rounds. Their latest funding was raised on May 12, 2017 from a Series A round. HealthReveal is funded by five investors. As of March 2020, Northwell VenturesNorthwell Ventures and Flare Capital Partners are the most recent investors. The company's advanced analytics and biomonitoring technology continually monitors and analyzes patient physiology and care by integrating multiple real-time streams of clinical, operational and biometric data to ensure adherence to evidence-based care guidelines by clinicians and patients which helps patients.

HealthReveal is a clinical AI company in New York that focuses on enabling detection and treatment of chronic ailments at early stages. Founded 2015 in New York, United States by Frank Norman, Lonny Reisman, and Lori Evans Bernstein, HealthReveal has raised a total of $11.3M in funding over two rounds. Their latest funding was raised on May 12, 2017 from a Series A round. HealthReveal is funded by five investors. As of March 2020, Northwell Ventures and Flare Capital PartnersFlare Capital Partners are the most recent investors. The company's advanced analytics and biomonitoring technology continually monitors and analyzes patient physiology and care by integrating multiple real-time streams of clinical, operational and biometric data to ensure adherence to evidence-based care guidelines by clinicians and patients which helps patients.

HealthReveal is a clinical AI company in New York that focuses on enabling detection and treatment of chronic ailments at early stages. Founded 2015 in New York, United States by Frank Norman, Lonny Reisman, and Lori Evans Bernstein, HealthReveal has raised a total of $11.3M in funding over two rounds. Their latest funding was raised on May 12, 2017 from a Series A round. HealthReveal is funded by five investors. As of March 2020, Northwell Ventures and Flare Capital Partners are the most recent investors. The company's advanced analytics and biomonitoring technology continually monitors and analyzes patient physiology and care by integrating multiple real-time streams of clinical, operational and biometric data to ensure adherence to evidence-based care guidelines by clinicians and patients which helps patients.